Return to Article Details
TREATMENT RESULTS OF ADVANCED NON SMALL-CELL LUNG CANCER HARBOURING UNCOMMON EGFR MUTATIONS BY FIRST AND SECOND GENERATION TYROSINE KINASE INHIBITORS
Download
Download PDF